CERT Certara

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

  • Baird Global Healthcare Conference

    Date and Time:     Tuesday, September 9 at 10:15 a.m. ET

  • Morgan Stanley 23rd Annual Global Healthcare Conference

    Date and Time:     Wednesday, September 10 at 12:20 p.m. ET

Live webcasts for each of the conferences will be available on Certara’s investor relations website at and will be available for replay for at least 90 days thereafter.

About Certara

Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.

Investor Relations Contact:

David Deuchler

Gilmartin Group

Media Contact:

Alyssa Horowitz



EN
02/09/2025

Underlying

CERTCertara

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Certara

 PRESS RELEASE
Free
CERT CERTARA

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara Scientists are Among the Topmost Cited Biopharma Researchers Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025 RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research. With more than 200 papers authored by Certara scientists* this past year and 11 Certara scientists included on the  of the top 2% most cited scientists across the globe, Certara’s powerhouse of scientific k...

October 20, 2025 1 EN
 PRESS RELEASE
Free
CERT CERTARA

Certara to Report Third Quarter 2025 Financial Results on November 6th...

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to . It is recommended to register at least one day in advance. A live and archived webcast of the event...

October 10, 2025 1 EN
 PRESS RELEASE
Free
CERT CERTARA

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Su...

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurements RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the availability of . The solution enables clinical and statistical programmers to efficiently create, reuse, and manage required data specifications for creating the CDISC Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) datasets. These dataset...

September 4, 2025 1 EN
 PRESS RELEASE
Free
CERT CERTARA

Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Global Healthcare ConferenceDate and Time: Tuesday, September 9 at 10:15 a.m. ET Morgan Stanley 23rd Annual Global Healthcare ConferenceDate and Time: Wednesday, September 10 at 12:20 p.m. ET Live webcasts for each of the conferences will be available on Certara’s investor relations website at and will...

September 2, 2025 1 EN
 PRESS RELEASE
Free
CERT CERTARA

Certara Reports Second Quarter 2025 Financial Results 

Certara Reports Second Quarter 2025 Financial Results  Reiterates Full Year 2025 Financial Guidance RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025. Second Quarter Highlights: Revenue was $104.6 million, compared to $93.3 million in the second quarter of 2024, representing growth of 12%. Software revenue was $46.7 million, compared to $38.2 million in the second quarter of 2024, representing growth of 22%.Service revenue ...

August 6, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch